Iterative Therapeutics, Inc. v. Kappos

CourtDistrict Court, District of Columbia
DecidedMarch 8, 2010
DocketCivil Action No. 2009-1822
StatusPublished

This text of Iterative Therapeutics, Inc. v. Kappos (Iterative Therapeutics, Inc. v. Kappos) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Iterative Therapeutics, Inc. v. Kappos, (D.D.C. 2010).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ______________________________ ) ITERATIVE THERAPEUTICS, INC, ) ) Plaintiff, ) ) v. ) Civil Action No. 09-1822 (RWR) ) DAVID KAPPOS, ) ) Defendant. ) ______________________________)

MEMORANDUM ORDER

In light of the Federal Circuit’s decision in Wyeth v.

Kappos, 591 F.3d 1364 (Fed. Cir. 2010), the Director of the

United States Patent and Trademark Office (“USPTO”) has moved to

vacate a 263-day patent term adjustment it issued regarding a

patent that was assigned to Iterative Therapeutics, Inc. (“ITI”).

(“Def.’s Mot. for Vacatur of Patent Term Calc. and Remand to the

USPTO (“Def.’s Mot.”) at 1.) The USPTO and the Department of

Justice have decided not to seek further appellate review of the

Wyeth opinion, and the USPTO has published in the Federal

Register an interim procedure by which patentees may request a

recalculation of the term adjustment for their patents. The

procedure also could be applied to ITI’s request for a patent

term adjustment if the case were remanded. (Def.’s Mot. at 2.)

ITI argues that it would be prejudiced by a remand, claiming it

would have no recourse to challenge an erroneous recalculation,

and speculating that there could be future third-party challenges -2-

to the recalculation method used on remand causing more

litigation expense to ITI.

ITI’s arguments are misplaced. Even if exposure to a

potential future third-party challenge to a USPTO recalculation

were actually cognizable prejudice - - a proposition for which

ITI offers no support - - there is nothing that would immunize

from challenge a recalculation litigated in district court.

Preventing remand offers ITI no refuge as to that issue. And,

any challenge that ITI may want to make to a USPTO recalculation

on remand can be brought in this court as jurisdiction over the

case will be retained here during the remand.1 Therefore, it is

hereby

ORDERED that ITI’s existing patent term calculation be, and

hereby is, VACATED. It is further

ORDERED that this case be, and hereby is, REMANDED to the

USPTO for recalculation and adjustment of the disputed patent

term in accordance with the Wyeth opinion and the USPTO’s

published interim procedure for such calculations. This court

1 Moreover, affording the agency charged in the first instance with the duty to calculate patent terms the opportunity to perform the recalculation would allow for a well-developed record below for this court to review should ITI seek to challenge the recalculation. To the extent ITI opposes remand because it wants to “settle[] . . . this case expeditiously” (Pl.’s Resp. to Order to Show Cause and Opp’n to Def.’s Mot. at 4.), it can pursue settlement at any time regardless of the forum in which its challenge is pending. -3-

will retain jurisdiction to entertain any challenge to the

recalculation.

SIGNED this 8th day of March, 2010.

/s/ RICHARD W. ROBERTS United States District Judge

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wyeth v. Kappos
591 F.3d 1364 (Federal Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Iterative Therapeutics, Inc. v. Kappos, Counsel Stack Legal Research, https://law.counselstack.com/opinion/iterative-therapeutics-inc-v-kappos-dcd-2010.